PubMed Central (PMC) Search Page
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 1997 | 1 |
| 2000 | 2 |
| 2002 | 1 |
| 2005 | 2 |
| 2006 | 10 |
| 2007 | 9 |
| 2008 | 21 |
| 2009 | 32 |
| 2010 | 34 |
| 2011 | 75 |
| 2012 | 113 |
| 2013 | 121 |
| 2014 | 125 |
| 2015 | 126 |
| 2016 | 126 |
| 2017 | 142 |
| 2018 | 198 |
| 2019 | 163 |
| 2020 | 121 |
| 2021 | 99 |
| 2022 | 149 |
| 2023 | 121 |
| 2024 | 104 |
| 2025 | 124 |
| 2026 | 103 |
-
Publication date
-
-
Publication stage
These filters represent the three primary types of content included in the PMC archive: 1) content published in a scholarly journal 2) peer-reviewed author manuscripts accepted for publication in a journal and 3) preprint versions of articles collected through the NIH Preprint Pilot, made public prior to peer review
-
-
Collections
The PMC Open Access Subset includes journal articles and preprints that are made available under license terms that allow reuse. Historical back issues refers to digitized content from print journals made available in PMC through the Biomedical Journal Digitization Projects.
-
"Int J Oncol"[Journal]
The embargo is the time during which the publisher retains exclusive rights to distribute articles. Those articles are made freely available on the PMC website after the embargo period has ended. Citations for articles under an embargo period will still display in the PMC results list by default. Choose “Exclude” to prevent embargoed articles from displaying in your results.
-
[Corrigendum] Monoamine carboxylate transporters are involved in BI-1-associated cancer metastasis in HT1080 colon fibrosarcoma cells.
- Lee GH, Chae HJ, Kim HR.
- Int J Oncol. 2026 Oct 23;69(6):138. doi: 10.3892/ijo.2026.5951.
- PMCID: PMC13687821
Lee GH, et al.Int J Oncol. 2026.PMCID: PMC13687821 -
[Corrigendum] Acquired resistance of pancreatic cancer cells to treatment with gemcitabine and HER‑inhibitors is accompanied by increased sensitivity to STAT3 inhibition.
- Ioannou N, Seddon AM, Dalgleish A, Mackintosh D, Solca F, Modjtahedi H.
- Int J Oncol. 2026 Oct 16;69(6):135. doi: 10.3892/ijo.2026.5948.
- PMCID: PMC13681071
Ioannou N, et al.Int J Oncol. 2026.PMCID: PMC13681071 -
Effect of xeroderma pigmentosum group C on the characteristics and regulatory mechanisms of lung cancer stem cells.
- Yang B, Yang Y, Wang W, Wang Y, Wang H, Qin L, Wang Y, Sun S, Wang S, Qu M.
- Int J Oncol. 2026 Sep 4;69(4):120. doi: 10.3892/ijo.2026.5933.
- PMCID: PMC13553190
Yang B, et al.Int J Oncol. 2026.PMCID: PMC13553190 -
MicroRNA regulation of macrophage polarization in lung cancer: Regulatory networks and therapeutic potential (Review).
- Yiming Z, Jie L.
- Int J Oncol. 2026 Sep 4;69(4):121. doi: 10.3892/ijo.2026.5934.
- PMCID: PMC13553194
Yiming Z, et al.Int J Oncol. 2026.PMCID: PMC13553194 -
Post‑translational modification‑governed immune states in cancer immunity: Biomarker implications for checkpoint competence, tumor visibility and immunotherapy resistance (Review).
- Pan J, Li B, Lin R, Fang C, Lau LY, Hong Z, Chen Y.
- Int J Oncol. 2026 Aug 21;69(4):119. doi: 10.3892/ijo.2026.5932.
- PMCID: PMC13553192
Pan J, et al.Int J Oncol. 2026.PMCID: PMC13553192 -
[Corrigendum] Sulforaphane reduces molecular response to hypoxia in ovarian tumor cells independently of their resistance to chemotherapy.
- Pastorek M, Simko V, Takacova M, Barathova M, Bartosova M, Hunakova L, Sedlakova O, Hudecova S, Krizanova O, Dequiedt F, Pastorekova S, Sedlak J.
- Int J Oncol. 2026 Aug 21;69(4):118. doi: 10.3892/ijo.2026.5931.
- PMCID: PMC13553189
Pastorek M, et al.Int J Oncol. 2026.PMCID: PMC13553189 -
Single in situ intratumoral low‑dose shikonin hydrogel plus mild photothermal therapy elicits systemic antitumor immunity in immune‑cold triple‑negative breast cancer.
- Pan T, Feng Z, Shang T, Jiang J, Zhang F.
- Int J Oncol. 2026 Aug 21;69(4):117. doi: 10.3892/ijo.2026.5930.
- PMCID: PMC13553191
Pan T, et al.Int J Oncol. 2026.PMCID: PMC13553191 -
KIAA1429 knockdown alleviates osteosarcoma progression by destabilizing SLC7A11 mRNA via m6A methylation to promote ferroptosis.
- Zeng H, Zhong Y, Zeng D, Xiao S, Zou S.
- Int J Oncol. 2026 Aug 21;69(4):116. doi: 10.3892/ijo.2026.5929.
- PMCID: PMC13553193
Zeng H, et al.Int J Oncol. 2026.PMCID: PMC13553193 -
The pivotal role of SCD1 in digestive cancers: Bridging lipid metabolic reprogramming and programmed cell death (Review).
- Fu Y, Wang Z, Liu L, Tang X.
- Int J Oncol. 2026 Aug 14;69(4):112. doi: 10.3892/ijo.2026.5925.
- PMCID: PMC13496939
Fu Y, et al.Int J Oncol. 2026.PMCID: PMC13496939 -
Signaling pathways and targeted therapy in high‑risk refractory thyroid cancer: From bench to bedside (Review).
- Wang J, Liu Z, Zhang Q, Sun W.
- Int J Oncol. 2026 Aug 14;69(4):114. doi: 10.3892/ijo.2026.5927.
- PMCID: PMC13496938
Wang J, et al.Int J Oncol. 2026.PMCID: PMC13496938